Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...

A University of Pennsylvania biotechnology company that aims to treat autoimmune diseases by reengineering cells within the ...

Researchers at the University of Würzburg have discovered a process that breaks down mRNA molecules in the human body ...

The mRNA market is projected to reach $63.28 billion by 2025, indicating an all-time high global demand for mRNA vaccines and therapeutics. Now more than ever, robust process development and ...

The new process aims to precipitate out mRNA while keeping impurities in solution. It uses two tangential flow filters (TFF), one to remove impurities and a second to take out the precipitating ...

3 rd Annual mRNA Process Development & Manufacturing Summit - members of Applied DNA's Biotherapeutics Sales and Business Development teams (collectively 'LineaRx,' a majority-owned Applied DNA ...

The 3rd mRNA Process Development and Manufacturing Summit returns to Boston this September, poised to help you implement high throughput process development, scale-up mRNA synthesis and purification, ...

The 3 rd mRNA Process Development & Manufacturing Summit 2025 returns as Europe’s premier industry-focused forum, dedicated to optimizing process development for mRNA therapeutics and vaccines.

3 rd Annual mRNA Process Development & Manufacturing Summit - members of Applied DNA's Biotherapeutics Sales and Business Development teams (collectively 'LineaRx,' a majority-owned Applied DNA ...

3 rd Annual mRNA Process Development & Manufacturing Summit - members of Applied DNA's Biotherapeutics Sales and Business Development teams (collectively 'LineaRx,' a majority-owned Applied DNA ...